Institute of Biophysics and Cell Engineering-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2021

  1. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

    Dalton Transactions, Vol. 50, Núm. 27, pp. 9500-9511

2020

  1. Ruthenium dendrimers against human lymphoblastic leukemia 1301 cells

    International Journal of Molecular Sciences, Vol. 21, Núm. 11, pp. 1-13

2019

  1. Synthesis and characterization of FITC labelled ruthenium dendrimer as a prospective anticancer drug

    Biomolecules, Vol. 9, Núm. 9

2017

  1. Binding of poly(amidoamine), carbosilane, phosphorus and hybrid dendrimers to thrombin—Constants and mechanisms

    Colloids and Surfaces B: Biointerfaces, Vol. 155, pp. 11-16

2012

  1. Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: Characterization of dendriplexes

    Journal of Biomedical Nanotechnology, Vol. 8, Núm. 1, pp. 57-73

2011

  1. Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1

    Colloids and Surfaces B: Biointerfaces, Vol. 83, Núm. 2, pp. 388-391